About Molecular Partners AG Molecular Partners AG is a clinical-stage biotech company that is developing a new class of therapies known as DARPin® therapeutics. The company continues to attract talented individuals who share the passion to develop breakthrough medicines for serious diseases. Molecular Partners has compounds in various stages of clinical and preclinical development and several more in the research stage, with a current focus on immuno-oncology and infectious disease. The company conducts research and development both internally and in partnerships with leading pharmaceutical companies and is backed by top biotech investors.